Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous regimens to prevent post-dural puncture headache after spinal anesthesia for elective cesarean section
PACTR202412781041756Phase 3Recruiting
- Sponsor
- Al-Azhar University
- Start
- Dec 2024
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of neostigmine, aminophylline, tetracosactide hexaacetate and standard IVF medium in post-dural puncture headache (PDPH) (4 arms), sponsored by Al-Azhar University. Primary endpoint: Incidence of post-dural puncture headache after spinal anesthesia. Started Dec 2024; status: recruiting.
02
Drugs
neostigmineaminophyllinetetracosactide hexaacetatestandard IVF medium
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on PACTR202412781041756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202412781041756.